Bill, living with transthyretin amyloidosis, and his wife, Maura ntellia Intellia is Leading the Genome Editing Revolution Corporate Overview MARCH 2022 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs a ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2021 Earnings Conference Call February 24, 2022 8:00 AM ET Company Participants Ian Karp ??? Senior Vice President-Investor Relations and Corporate Communications John Leonard ??? Chief Executive Officer Glenn Goddard ??? Chief Financial Officer David Lebwohl ??? Chief Medical Officer Laura Sepp-Lorenzino ??? Chief Scientific Officer Conference Call Participants Operator Good morning, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 2021 Fina ...

Bill, living with transthyretin amyloidosis, and his wife, Maura o real Corporate Overview November 2021 THERAPEUTIC 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding our: abili ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2021 Results Conference Call November 4, 2021 8:00 AM ET Company Participants Ian Karp - SVP, IR and Corporate Communications Dr. John Leonard - CEO Dr. David Lebwohl - Chief Medical Officer Dr. Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - CFO Conference Call Participants Maury Raycroft - Jefferies Joon Lee - Truist Securities Rick Bienkowski - SVB Leerink Xiaobin Gao - Barclays Luca Issi - RBC Liisa Bayko - Evercore ISI Yanan Zhu - Wells Fargo ...

Bill, living with transthyretin amyloidosis, and his wife, Maura o E Corporate Overview October 2021 THERAPE 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding our: ability to co ...

Call Start: 08:00 January 1, 0000 9:00 AM ET Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2021 Earnings Conference Call August 5, 2021 08:00 ET Company Participants Ian Karp - Senior Vice President of Investor Relations & Corporate Communications John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientific Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Joon Lee - Truist Securities Luca Issi - RBC ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2021 Results Earnings Conference Call May 6, 2021 8:00 AM ET Company Participants Lina Li - Director of Investor Relations John Leonard - President and Chief Executive Officer David Lebwohl - Executive Vice President and Chief Medical Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President and Chief Financial Officer Conference Call Participants Sonya Bhatia - Goldman Sachs Maury Raycroft - Jef ...

Bill, living with transthyretin amyloidosis, and his wife, Maura o real Corporate Overview February 2021 THERAPEU 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding our: being ab ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2020 Earnings Conference Call February 25, 2021 8:00 AM ET Company Participants Josh Rappaport - Investor Relations John Leonard - Chief Executive Officer David Lebwohl - Chief Medical Officer Laura Sepp-Lorenzino - Chief Scientist Officer Glenn Goddard - Chief Financial Officer Conference Call Participants Maury Raycroft - Jefferies Rick Bienkowski - SVB Leerink Timur Ivannikov - Raymond James Joon Lee - Truist Securities Yanan Zhu - Wells Fargo Tashdid Hasan - ...

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President and Chief Executive Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President, Chief Financial Officer David Lebwohl - Executive Vice President and Chief Medical Officer Conference Call Participants Salveen Richter - Goldman Sachs Maury Raycroft - Jeffer ...